Linc
83.6
SEK
-1.53 %
LINC
NASDAQ Stockholm
Investment
Financials
Be the first to follow this company
-1.53%
+8.43%
-5.22%
-5%
+29.41%
+23.85%
-10.07%
-
-1.65%
Linc is an investment company. The company specializes in investment, ownership, and further management of companies in the Life Science industry. The investments are mainly made in small and medium-sized product-oriented life science companies in medical technology and pharmaceuticals. The vision is to be an active and long-term owner. The largest share of investments takes place in the Nordic region.
Read moreMarket cap
4.84B SEK
Turnover
2.9M SEK
Revenue
-
EBIT %
-
P/E
7.81
Dividend yield-%
-
Financial calendar
23/1
2025
Annual report '24
23/4
2025
Interim report Q1'25
17/7
2025
Interim report Q2'25
ShowingAll content types
Substansvärde 2024 10 31
Delårsrapport Linc AB (publ) 1 januari – 30 september 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools